Does Quinolone- or Macrolide-Resistant Streptococcus agalactiae Bacteremia Affect Patient Outcome? A Multicenter Cohort Study

Satoru Mitsuboshi; Junichiro Date; Naoki Tsuruma; Hirokazu Yamaga; Kazuya Watanabe; Hiroko Kijima; Manami Nakashita; Hiroki Hosokawa; Masami Tsugita

doi:10.7883/yoken.JJID.2020.589

Short Communications

Does Quinolone- or Macrolide-Resistant Streptococcus agalactiae Bacteremia Affect Patient Outcome? A Multicenter Cohort Study

Satoru Mitsuboshi, Junichiro Date, Naoki Tsuruma, Hirokazu Yamaga, Kazuya Watanabe, Hiroko Kijima, Manami Nakashita, Hiroki Hosokawa, Masami Tsugita

著者情報

キーワード: Streptococcus agalactiae, quinolone, macrolide, resistance

ジャーナルフリー

2021 年 74 巻 3 号 p. 240-244

DOI https://doi.org/10.7883/yoken.JJID.2020.589

Browse “Advance online publication” version

詳細

抄録

The prevalence of quinolone- and macrolide-resistant Group B Streptococcus (GBS) is increasing worldwide, but the relationship between the resistance of GBS to these antibiotics and patient outcome remains unclear. Therefore, we evaluated whether blood stream infection caused by quinolone- or macrolide-resistant GBS is associated with high mortality. Our findings in 77 patients with GBS bacteremia demonstrate that quinolone and macrolide resistance may not be risk factors for 30-day mortality.

責任著者(Corresponding author)

J-STAGEへの登録はこちら（無料）